Bicycle Therapeutics (NASDAQ:BCYC) Shareholders Have Endured a 74% Loss From Investing in the Stock Three Years Ago

Yahoo FinanceFeb 5 07:13 ET

Bicycle Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

BusinesswireFeb 5 07:00 ET

European Equities Traded in the US as American Depositary Receipts Rise Thursday

MT NewswiresJan 16 11:21 ET

Optimistic Outlook on Bicycle Therapeutics Amid Mixed Clinical Results and Strategic Roadmap

TipRanksJan 15 01:58 ET

A Quick Look at Today's Ratings for Bicycle Therapeutics(BCYC.US), With a Forecast Between $26 to $40

Moomoo NewsJan 14 08:00 ET · Ratings

Express News | Bicycle Therapeutics PLC : Leerink Partners Cuts Target Price to $26 From $28

ReutersJan 14 00:06 ET